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ABSTRACT 
 
Pyridoxal Phosphate as a Tag to  
Identify Enzymes Within the “PLP-ome.”  (May 2011) 
Kayla J. Messer, B.S.,Cabrini College 
Chair of Advisory Committee: Dr. Tadhg P. Begley 
 
The main objective of this research was to develop a protocol in which pyridoxal 
phosphate (PLP) would act as a tag to identify PLP-dependent enzymes from complex 
mixtures or cell lysates.  Following the purification of a PLP-dependent enzyme (CysM), 
a method was developed to reduce the PLP-lysine Schiff base to form a chemically 
stable bond between the PLP and the protein.  The reduced protein was enzymatically 
digested resulting in multiple peptide fragments with one or more containing PLP 
(bound to the active site lysine).  These fragments were analyzed by monitoring the 
absorbance or fluorescence using High Performance Liquid Chromatography. 
Immobilized Metal Ion Affinity Chromatography (IMAC) was then used to enrich the 
PLP-peptide(s) from the peptide mixture.  The PLP-bound peptide(s) was then analyzed 
using Liquid Chromatography-Mass Spectrometry (LC-MS).   
More specifically, sodium borohydride (NaBH4) was used to reduce the Lysine-
PLP bond in CysM.  This reaction was monitored by either UV-vis spectroscopy or mass 
spectrometry.  Trypsin was used to enzymatically digest the reduced CysM before it was 
enriched with IMAC and analyzed with LC-MS.  Since the objective of this project was 
iv 
 
to develop a method which could be applied to a cell lysate, IMAC was used as an 
enrichment method to separate the PLP-peptide(s) from other peptides within the 
mixture.  The PLP-peptide(s) was then located in the peptide mixture by monitoring the 
absorbance at 325 nm.  The LC-MS results of the full reaction before IMAC treatment 
versus the final column, when monitoring the mass spectrum, showed that the treatment 
using the IMAC column separated the PLP-peptides from all other peptides within the 
sample.  Using IMAC to enrich specifically the PLP-peptides, followed by analysis with 
LC-MS, may be a useful method for studying PLP-dependent enzymes within the 
proteome or the “PLP-ome.” 
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1. INTRODUCTION: THE IMPORTANCE OF PYRIDOXAL PHOSPHATE 
  
Pyridoxal 5’phosphate (PLP) was first identified in 1951 as one of the active 
vitamers of vitamin B6.
1
  An extensive amount of research has been conducted since then 
to understand its catalytic versatility.   PLP-dependent enzymes have attracted attention 
due to their widespread involvement in cellular processes.  PLP-dependent enzymes are 
mainly involved in the biosynthesis of amino acids and amino acid-derived metabolites 
as well as in the biosynthetic pathways of amino sugars and other amine-containing 
compounds.
2
   
PLP is a cofactor utilized by numerous biologically important enzymatic 
reactions including transaminations, decarboxylations and racemizations.  In many of 
these reactions, PLP acts as an “electron sink” withdrawing electrons and forming 
imines with amino groups of corresponding substrates.
3
  In most PLP-dependent 
reactions, the carbonyl group of PLP binds to the amino group of a lysine residue in the 
active site.  This results in the formation of a Schiff base.
3
   During catalysis, the amino 
group of the substrate replaces the enzyme lysine of the Schiff base to form an external 
aldimine.
4
  The lysine residue within the active site plays a crucial role during catalysis.  
The cross-linking of the PLP to the enzyme active site, allows one to identify the 
essential lysine in the PLP-binding site. 
Structurally characterized PLP-dependent enzymes have been found to belong to  
 
____________ 
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five distinct structural groups identified as fold-types I-V.
5
  These five structural groups 
are presumed to correspond to five independent evolutionary lineages.
6
  Fold-type I is  
found in a variety of amino transferases and decarboxylases including enzymes that 
catalyze α-, β- or γ-eliminations.7  Fold-type I is also the most common structural group.  
Fold-type II is found in enzymes that catalyze β-elimination reactions.7    Fold-type III is 
found in alanine racemase as well as in a subset of amino-acid decarboxylases.
7
  Fold-
type II is also characterized by a (β/α)8 barrel structure.
7
  D-alanine aminotransferase and 
a few other enzymes consist of the Fold-type IV enzymes.
7
  The fold-type V enzymes 
include glycogen and starch phosphorylases.
7
  The limitations in structural diversity 
have been used to identify PLP-dependent enzymes from genomic sequences by using 
methods that identify the structural conservation of protein families.
6
 
The importance of PLP-enzymes is exemplified by the number identified as drug 
targets.  For example, the treatment of epilepsy has been improved through the inhibitors 
of γ-aminobutyric acid aminotransferase (GABA ATase).8  Serine hydroxymethyl 
transferase (SHMT) has also been identified as a target for cancer therapy.
9
  The 
inhibitors of ornithine decarboxylase (ODC) have even been used in the treatment of 
African sleeping sickness.
10
  Furthermore, functional defects in PLP enzymes have also 
been implicated in disease pathologies including homocystinuria which is mainly linked 
to mutations in cystathionine β-synthase.11  However, there are still many PLP-enzymes 
that have not been identified or characterized. 
  The number of genes that code for PLP-dependent enzymes in free-living 
microorganisms depends on the organism’s adaptations to specific nutrient sources.7  
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Methanococcus jannaschii has the smallest number of genes (a total of 20) which is 
probably due to its peculiar nutrient requirements.
7
  Generally, there are between 20 and 
30 genes encoding PLP-dependent enzymes in archaeal organisms with slightly higher 
numbers found in bacteria with small genomes (ex. Clostridium perfringens).
7
  Almost 
1.5% of all prokaryotic genes code for PLP-dependent enzymes, but this number 
drastically decreases within higher eukaryotes.
7
  This is consistent with the hypothesis 
that PLP-dependent enzymes are mainly involved in basic metabolism.
7
  These enzymes 
are functionally diverse with more than 140 distinct enzymatic activities, catalogued by 
the Enzyme Commission, dependent upon PLP.
7
  Nevertheless, detailed questions 
referring to the importance, distribution and diversity of PLP-dependent enzymes remain 
unanswered.   
A two-step approach has been used to learn more about these enzymes.
7
  The 
first step involves surveying genomic sequences to obtain an outline of the genomic 
distribution of PLP-dependent enzymes.
7
  The second step involves investigating aspects 
of the results by relating them to general issues relevant to the genomic analysis of 
protein families.
7
  This approach is not only time consuming but is problematic 
considering that a one-to-one correspondence between functions and genes should not be 
expected.
7
  The assignment of function cannot rely solely on bioinformatics, but must be 
supplemented with emerging high-throughput technologies to supply necessary 
biochemical data.  
Even though there is a fairly long history of research in this field, there are many 
unanswered questions regarding this versatile cofactor.   To learn more about PLP-
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dependent enzymes, a versatile method for investigating the proteome’s PLP-dependent 
enzymes must be developed.  To begin this investigation, the Schiff base could be 
reduced with sodium borohydride (NaBH4) to form a chemically stable secondary amine. 
This would allow further research on the PLP-protein complex.  The reduction of a 
Schiff base to form a covalent, chemically stable, PLP-bound protein is shown in Figure 
1-1.  To identify the PLP-protein from a complex mixture, an enrichment method may 
need to be applied in order to elucidate low-abundance proteins of interest in the 
presence of a large excess of relatively abundant proteins.
12
  It becomes crucial to enrich 
the sample in order to perform effective proteome analysis.  Methods for enriching 
specific phosphorylated proteins have been developed for the enrichment of 
phosphoserine/threonine-containing proteins, phosphotyrosine-containing proteins as 
well as for nonspecific proteins.  One of the most reliable methods for enriching  
non-specific proteins is immobilized metal ion affinity chromatography (IMAC).
12
   
Anderson and Porath first observed that phosphorylated amino acids and proteins 
selectively bind to Fe(III) charged iminodiacetic acid (IDA) agarose.
13
  The two most 
commonly utilized chelating groups are iminodiacetic acid and nitrilotriacetic acid 
(NTA).  These groups are then immobilized on chromatographic resins, membranes or 
magnetic beads.
13
  Consequently, the number of available coordination sites depends 
upon the chelating group.  The NTA chelating group is a quadridentate chelating 
absorbent.
14
  The NTA derivative occupies four positions in the metal coordination 
sphere of nickel (Ni
2+
) leaving two positions available for PLP to coordinate.
14
  For 
elution, the strategy is similar to those used during the purification of his-tagged 
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Figure 1-1.  The reduction of a PLP-protein with NaBH4 resulting in a chemically stable 
PLP-bound protein.  This figure shows the results following NaBH4 reduction of the 
Schiff base formed between the PLP and lysine residue of CysM. 
 
proteins.  Either an excess amount of free ligand (in this case being phosphates) or a shift  
in pH can be used to release the phosphorylated proteins from the chelating group.  The  
selective affinity for phosphorylated proteins, as well as the reversibility of the binding, 
has been exploited in the enrichment of phosphorylated proteins from complex 
samples.
13
  Overall, IMAC relies upon the affinity of the phosphate group to metal ions 
immobilized on a matrix via acidic compounds such as NTA.
15
   
IMAC has not only been used to enrich phosphoproteins/peptides but also to 
separate various phosphoisoforms of the same protein.  Andersson and Proath showed 
that they could separate phosphoisoforms of ovalbumin using a Fe(III)-IDA matrix and a 
pH gradient from 5.7-7.2.
13
  Various phosphoisoforms of tomatosucrose synthase were 
also isolated by applying a basic gradient from pH 6.3-9.5.
16
  IMAC has also been 
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applied to extract large numbers of phosphoproteins in proteomic studies.  Fusion 
proteins have been captured by a Fe(III)-NTA matrix and then eluted with a mixture of 
high pH and competition of phosphate ions.
17
  In a similar procedure, Jurkat T cells were 
analyzed by capturing the phosphoproteome on a Fe(III)-NTA matrix at acidic pH and 
eluted at pH 8.5.
18
  Based upon these studies, IMAC seems to be a viable candidate for 
enriching the PLP-peptides from a peptide mixture.  Nonetheless, a single PLP-
dependent enzyme must first be selected as a model for method development. 
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2.   A PLP-DEPEDENT ENZYME MODEL - CYSTEINE SYNTHASE 
 
2.1  Introduction 
Mycobacterium tuberculosis is a hazardous pathogen that wreaks havoc on the 
human population from both a medicinal and a financial vantage point.  In the dormant 
phase, this organism survives in the granulomas within the lungs of the infected 
individual(s).
19
  This environment is characterized by hypoxia, nutrient starvation as well 
as oxidative stress.
20
  Oxidative stress results in nitrogen monoxide and spontaneously 
formed reactive nitrogen intermediates which are used by the host’s phagocytic cells to 
kill the internalized bacteria.  The primary targets of the nitrogen intermediates include 
cysteine and tyrosine side chains.
21
  In Mycobacterium tuberculosis, the principle thiol 
responsible for maintaining the redox balance contains a cysteine-derived cysteamine 
moiety.
22
  As a result, this pathogen’s first line of defense against free radicals is directly 
dependent upon the availability of cysteine.
22
  Consequently, the inhibition of cysteine 
biosynthesis has been studied as a potential target for antibacterial agents to combat this 
pathogen.
23
   
In order to treat and potentially control the adverse symptoms caused by this 
pathogen, a full understanding of its biological machinery was first required.  The M. 
tuberculosis genome affords four loci assigned as encoding cysteine synthase enzymes, 
one of which is notated as CysM.
24
  The cysteine biosynthetic pathway of M. 
tuberculosis, which contains CysM, was previously reconstituted.
24
  The chemical  
mechanism of CysM has been proposed by Dr. Tadhg Begley’s lab.  This particular 
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Figure 2-1.  The crystal structure of CysM.  This figure shows the active site of CysM 
with the residue Lys51, of the protein, and the PLP cofactor shown in stick format. 
 
enzyme forms an imine between the CysM-bound pyridoxal 5’-phosphate and the amino 
acid substrate, followed by elimination across the α,β bond of the substrate to form a 
stable α-aminoacrylate intermediate.24  A thiocarboxylate adds to this intermediate 
resulting in a β-substituted amino acid imine.24  This imine then undergoes 
transimination with an active site lysine residue to release the product as well as 
regenerate the active site.
24
  Using the Protein Data Bank, the active site within the 
crystal structure of M. tuberculosis CysM is shown in Figure 2-1.  The PLP cofactor 
binds at lysine 51 making CysM a suitable candidate for PLP-peptide proteomics and 
method development. 
 
2.2  Results 
 2.2.1 CysM Expression and Purification. The Amp-LB plate from the 
transformation of BL21 DE3 E. coli with CysM is shown in Figure 2-2.  The growth  
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Figure 2-2.  CysM-BL21 colony growth on an Amp-LB plate.  This figure shows the 
colonies resulting from growth of the transformed E. coli BL12 DE3 cells. 
 
 
Figure 2-3.  CysM expression SDS-PAGE gel results.  Lane 1 – Ladder; Lane 2 – 0 
hours after inducing with IPTG; Lane 3 – 3 hours after inducing with IPTG; Lane 4 – 6 
hours after inducing with IPTG; Lane 5 – 20 hours after inducing with IPTG.  This  
10 
 
 
Figure 2-4.  CysM Ni-IMAC column during CysM purification.  This image shows the 
yellow band (indicated with a white arrow) at the top of the nickel column which 
indicated that the CysM protein was bound. 
 
resulted in many small colonies approximately 1 mM in diameter.  The gel results, from 
the protein expression, showed the expression of a new protein at approximately 34 kDa 
figure shows the successful expression of the CyM protein with a band at approximately 
34 kDa as indicated with an arrow which corresponds to the molecular weight of CysM 
(Figure 2-3).  During the purification, this particular protein was bright yellow colored as 
shown after it was added to the Ni-IMAC column during purification as shown in Figure 
2-4.   CysM was concentrated at the top of the column as a bright yellow substance until 
an appropriate concentration of imidazole buffer was used to elute it.  The protein eluted 
from the column between the 100-500 mM imidazole buffer washes.  The gel results 
from the protein purification are shown in Figure 2-5.  The gel results showed that most 
of the protein was eluted within the 500 mM imidazole buffer fraction.   
11 
 
 
Figure 2-5.  CysM purification SDS-PAGE gel results. Lane 1 – Ladder; Lane 2 – 0 
hours after inducing with IPTG; Lane 3 – 20 hours after inducing with IPTG; Lane 4 – 
Cell pellet; Lane 5 – Cell lysate; Lane 6 – 100 mM imidazole buffer wash; Lane 7 – 200 
mM imidazole buffer wash; Lane 8 – 500 mM imidazole wash (1 mL collection); Lane 9 
– 50% dilution of lane 8; Lane 10 – 500 mM imidazole wash (5 mL collection).  This 
figure shows the successful purification of the CysM protein with a band at 
approximately 34 kDa as indicated with a black arrow. 
 
2.2.2 CysM Reduction Under Basic Conditions.  The UV-vis spectrum of the 
CysM assay was taken before NaBH4 reduction, as well as at 5 and 30 minutes after 
NaBH4 addition.  These results (shown in Figure 2-6) indicated that a new peak formed 
as a “shoulder” at approximately 320 nm over the course of the reaction.  Also, the peak 
at 420 nm decreased over the course of the reaction.  The reduction of the Schiff base 
occurred after only 5 minutes of reaction time. After a reaction time of 5 minutes, the 
assays also changed from yellow to clear as shown in Figure 2-7. 
  
1
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Figure 2-6.  CysM UV-vis spectra following reduction with NaBH4 after 0 min, 5 min and 30 min.  This figure shows the 
successful reduction of the PLP-CysM through a decrease in the peak at 420 nm and an increase in the peak at 320 nm.  The 
reduction occurred after only 5 minutes of reaction time and the spectrum did not change after 30 minutes of reaction time.
13 
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Figure 2-7.  The reaction samples shown in clear 1 mL eppendorf tubes. These images 
show that the reduction of the PLP-CysM also resulted in a color change from yellow to 
clear after only a 5 minute reaction time. 
 
  1 MTRYDSLLQA LGNTPLVGLQ RLSPRWDDGR DGPHVRLWAK  
 41 LEDRNPTGSI KDRPAVRMIE QAEADGLLRP GATILEPTSG  
 81 NTGISLAMAA RLKGYRLICV MPENTSVERR QLLELYGAQI  
121 IFSAAEGGSN TAVATAKELA ATNPSWVMLY QYGNPANTDS  
161 HYCGTGPELL ADLPEITHFV AGLGTTGTLM GTGRFLREHV  
201 ANVKIVAAEP RYGEGVYALR NMDEGFVPEL YDPEILTARY  
241 SVGAVDAVRR TRELVHTEGI FAGISTGAVL HAALGVGAGA  
281 LAAGERADIA LVVADAGWKY LSTGAYAGSL DDAETALEGQ  
321 LWA 
 
Figure 2-8.  CysM amino acid sequence.  This figure shows the sequence of the CyM 
protein with the active site lysine residue (Lys51), with which PLP binds, shown in red. 
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 The CysM sequence is shown in Figure 2-8.  The purified protein also contained 
a His-tag with the following amino acid sequence: mghhhhhhhhhhssghiugrh.  Using this 
sequence, as well as the increased mass due to the addition of PLP (321.0297 Da), the 
anticipated mass of the reaction product (in which the Schiff base was reduced) was 
determined to be 37062 Da and the mass of the control (in which the Schiff base that 
was not reduced) was determined to be 36829.5 Da.  The results, analyzed by Pei-Jing 
“Peggy” Pai, Ph.D. (from Dr. Russell’s group at Texas A&M University), are shown in 
Figure 2-9.  The unmodified protein is shown in the top spectrum (the control) and the 
modified protein, with PLP bound, is shown in the bottom spectrum (the reaction).  The 
reduction of the Schiff base resulted in an increase of approximately 231 Da within the 
reaction (37058 Da) compared to the control (36827 Da).  There is also a 178 Da 
increase from 36827 Da to 37005 Da that corresponded to a glyconoylation.  The 
reaction spectrum also showed the PLP modification to the gluconoylated protein as an 
increase in mass from 37005 Da to 37238 Da.  The sample contained various salts or 
NaOH which complicated the sample analysis.  Removal of the salts or NaOH as well as 
allowing the NaBH4 reaction to occur for longer than 5 minutes would result in a greater 
concentration of PLP-modified protein and a cleaner spectrum.   
2.2.3 CysM Reduction Under Neutral Conditions.  The UV-vis spectrum of each 
sample was taken before NaBH4 reduction, 5 minutes after NaBH4 addition and 30 
minutes after NaBH4 addition.  The results confirmed the NaBH4 reduction of the PLP-
lysine bond and are shown in Figure 2-10.  A new peak formed as a “shoulder” at  
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Figure 2-9.  Mass spectrometry results from the NaBH4 reduction of CysM under basic conditions.  The top trace (pink) is the 
control without reduction of the Schiff base.  The bottom trace (blue) is the CysM full reaction with reduction of the Schiff 
base.  This figure shows the successful reduction of the CysM through the increase in the mass of the control (36827 Da) by 
231 Da to a mass of 37058 Da in the reaction.   
16 
 
 
1
6
 
 
 
Figure 2-10.  The UV-vis spectroscopy results of the NaBH4 reduction.  The full 
reaction, with the NaBH4 reduction, is shown in the red trace.  The control, without 
reduction, is shown in the blue trace.  This figure shows the successful reduction of the 
Schiff base through a decrease in the peak at 420 nm and an increase in the peak at 320 
nm. 
 
approximately 320 nm as well as a decrease in the height of the peak at 320 nm when the 
Schiff base was reduced. 
These samples were also submitted to Pei-Jing “Peggy” Pai, Ph.D. (from Dr. 
Russell’s group at Texas A&M University) for analysis with mass spectroscopy.  The 
result from the analysis of the control, without reduction of the Schiff base, is shown in 
Figure 2-11.  The result from the analysis of the reaction, with reduction of the Schiff 
base, is shown Figure 2-12.  These results clearly showed the addition of the PLP moiety 
with an increase in mass of approximately 231 Da.  These results show that the current  
  
1
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Figure 2-11.  Mass spectrometry results from the analysis of the control (in which the Schiff base was not reduced).  This 
figure shows the various ion charge states in the large spectrum with the deconvoluted spectrum shown in the inset.  This 
figure shows the molecular weight of the control being 36825.50 Da before reduction with NaBH4 (peak indicated with a star). 
  
1
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Figure 2-12.  Mass spectrometry results from the analysis of the full reaction (in which the Schiff base was reduced).  This 
figure shows the various ion charge states in the large spectrum with the deconvoluted spectrum shown in the inset.  This 
figure shows the resulting mass of the reduced CysM as 37057.40 Da (peak indicated with a  star).  Reduction of the Schiff 
base resulted in an increase of approximately 231.03 Da which corresponds to the addition of PLP. 
19 
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method for reduction worked appropriately and the reaction can be confirmed by either 
UV-vis spectroscopy or mass spectrometry. 
2.2.4 Immobilized Ion Metal Affinity Chromatography Enrichment.  MALDI was 
used to analyze the results after attempting to enrich the PLP-peptides from the CysM 
digest using the Fe-IMAC column.  The samples were prepared by Phillip Lang.  The 
peptide solutions were analyzed by Phillip in both negative and positive mode.  
Unfortunately, no peptides were found in the ammonium bicarbonate washings, where 
any bound phosphoproteins were expected to elute.   Based upon the fragmentation from 
trypsin digestion, the following peptides, containing the active site lysine (Lys51), were 
expected: 1) LEDRNPTGSIK – 1229.6484 Da; w/ PLP bound – 1460.6781 Da; 2) 
NPTGSIK – 716.3937 Da; w/ PLP bound – 947.4234 Da; 3) NPTGSIKDRPAVR – 
1410.7811 Da; w/ PLP bound – 1641.8108 Da.   
 2.2.5 Trypsin Digest of CysM and Analysis.  The UV-vis spectra confirmed the 
reduction of the Schiff base through a decrease in the peak at 420 nm and an increase in 
the peak at 325 nm.  These results are shown in Figure 2-13.  During the HPLC analysis, 
a peak at approximately 27 minutes was apparent in the reaction sample that was not 
present in the control (without NaBH4 reduction of the Schiff base).  This peak was 
apparent when monitored at 214 nm or 325 nm (neither of which was present in the 
control).  The results from monitoring the absorbance at both 214 nm and 325 nm are 
shown in Figure 2-14. 
 2.2.6 LC-MS Analysis of the Trypsin Digest of CysM.  The analysis of the  
absorbance traces (LC-MS) resulted in a peak when monitored at 214 nm in the full 
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Figure 2-13.  UV-vis spectra obtained from the CysM NaBH4 reduction.  The control 
(without reduction of the Schiff base) is shown in blue and the full reaction (with 
reduction of the Schiff base) is shown in red.  This result showed the successful 
reduction of the PLP-CysM through a decrease in the peak at 420 nm and an increase in 
the peak at 320 nm. 
 
reaction sample (with NaBH4 reduction of the Schiff base) at about 27.4 minutes that 
was not apparent in the control (without NaBH4 reduction of the Schiff base).  These 
results are shown in Figure 2-15.  Furthermore the control resulted in three peaks, when 
monitored at 214 nm, at about 7.4, 10.5 and 11.75 minutes that were not apparent in the 
reaction.  When monitoring at 325 nm, a peak was apparent in the reaction at about 27.4 
minutes as shown in Figure 2-16 (the same peak that showed up when monitored at 214 
nm).  The peak in the reaction with a retention time of about 27.4 was further analyzed 
using the mass spectroscopy portion of the LC-MS (see Figure 2-17).  This particular 
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Figure 2-14.  The HPLC results from analyzing the CysM trypsin digest.  This figure 
shows the results when monitoring the absorbance at 214 nm on the left and the results 
when monitoring the absorbance at 325 nm on the right.  The blue traces show the full 
reaction samples (with reduction of the Schiff base) and the red traces show the control 
samples (without reduction of the Schiff base). 
 
peak corresponded to an m/z value of 821.4329.  The peak was doubly charged resulting 
in an M+H value of 1641.8580 Da.  This particular peak corresponded to the mass of a 
peptide with the PLP bound at lysine 51 with a skipped trypsin cleavage site after the 
PLP bound lysine.  The expected peptide sequence was as follows: NPTGSIKDRPAVR 
(with a PLP bound at the center lysine).  Analysis of the two of the three new peaks that 
were apparent in the control (without NaBH4 reduction of the Schiff base) samples, 
when monitored at 214 nm, resulted in M+H values that corresponded to the expected 
peptides without PLP bound (NPTGSIK and DRPAVR). 
2.2.7 Purified CysM – Fluorescence Tests.  The UV-vis spectra that resulted 
from the reduction of CysM are shown in Figure 2-18.  These results confirmed the 
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reduction of the PLP-peptide through the increase in the peak at 320 nm and the decrease 
in the peak at 420 nm when comparing the control (without NaBH4 reduction of the 
Schiff base) and reaction (with NaBH4 reduction of the Schiff base).   The HPLC results 
when measuring fluorescence while varying the excitation wavelengths are shown in 
Figure 2-19.  The emission wavelength was kept the same at 395 nm while the excitation 
wavelengths were varied as 290 nm, 280 nm, 330 nm or 355 nm.  The excitation 
wavelengths resulting in the greatest intensity were 290 nm, 330 nm or 355 nm when the 
emission wavelength was 395 nm.  
The HPLC results when measuring fluorescence and varying the emission 
wavelengths are shown in Figure 2-20.  The excitation wavelength was kept the same at 
290 nm while varying the emission wavelength as 395 nm, 390 nm, 400 nm or 410 nm.  
These results showed that the emission wavelengths resulting in the greatest intensity 
were 395 nm, 390 nm or 400 nm when the excitation wavelength was 290 nm. 
The HPLC results when measuring fluorescence with an excitation wavelength of 290 
nm and an emission wavelength of 395 nm are shown in Figure 2-21.  Although the 
PLP-peptides at about 29.1 and 29.8 minutes were apparent when monitoring with 
fluorescence, there were many other peaks that were also apparent.  This showed that 
fluorescence was not as specific as monitoring the absorbance at 325 nm even though it 
was slightly more sensitive.   
The HPLC results when monitoring at an absorbance of 325 nm can be seen in 
Figure 2-22.  The traces for the trypsin control (with only trypsin present), control 
(without NaBH4 reduction of the Schiff base) and full reaction (with NaBH4 
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Full Reaction_1-A,4_01_62.d: UV Chromatogram, 214 nm NaBH4 control_1-A,3_01_61.d: UV Chromatogram, 214 nm  
Figure 2-15. LC-MS results comparing the CysM full reaction and control when monitoring the absorbance at 214 nm.  The 
result from the full reaction (with NaBH4 reduction of the Schiff base) is shown in the purple trace and the control (without 
NaBH4 reduction of the Schiff base) is shown in the green trace when monitoring the absorbance of both samples at 214 nm.  
These figure shows a peptide peak with a retention time of 27.4 minutes in the reaction that is not apparent in the control.
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Figure 2-16.  LC-MS results from the full reaction of CysM and the control monitoring absorbance at 325 nm.  The full 
reaction is shown in the blue trace and the control (without reduction of the Schiff base) is shown in the pink trace.  This 
figure shows that, when monitoring at 325 nm, a peak with a retention time of about 27.4 minutes was apparent in the reaction 
(with NaBH4 reduction of the Schiff base ) that was not apparent in the control (without NaBH4 reduction of the Schiff base). 
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Figure 2-17.  Further analysis of the peak in the reaction at 27.4 minutes (when monitoring absorbance at 325 nm) using the 
mass spectrum results from the LC-MS.  This figure shows that the peak with a retention time of 27.1 minutes corresponded 
to a m/z value of 821.4329.  This ion was doubly charged resulting in a “m” value or mass of about 1641.8580 Da which 
corresponded to the peptide: NPTGSIKDRPAVR.   
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Figure 2-18.  The UV-vis spectra results from the reduction of purified CysM.  This figure shows the successful reduction of 
the Schiff base through a decrease in the peak at 420 nm and an increase in the peak at 320 nm. 
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Figure 2-19.  The HPLC results when measuring fluorescence and varying the excitation wavelengths using the HPLC 1200 + 
FC.  The emission wavelength was kept at 395 nm.  The excitation wavelengths were 290 nm (blue), 280 nm (red), 330 nm 
(green) and 355 nm (pink).  This figure shows the excitation wavelengths that resulted in the greatest intensity were 290 or 
330 nm when the emission wavelength was 395 nm. 
 
  
 
2
8
 
 
 
Figure 2-20.  The HPLC results when measuring fluorescence and varying the emission wavelengths using the HPLC 1200 + 
FC.  The excitation wavelength was kept at 290 nm.  The emission wavelengths were 395 nm (blue), 390 nm (red), 400 nm 
(green) and 410 nm (pink).  This figure shows the emission wavelengths that resulted in the greatest intensity were 395, 390 
or 400 nm when the excitation wavelength was 290 nm.  
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reduction of the Schiff base) are shown.  These results emphasized that monitoring the 
absorbance was more selective than monitoring the fluorescence.  The PLP-peptides 
were apparent in the reaction at retention times of approximately 29.1 and 29.8 minutes. 
2.2.8. Modified IMAC Enrichment. The UV-vis spectra results from the reduction 
of CysM are shown in Figure 2-23.  The results confirmed the reduction of the PLP-
peptide through an increase in the peak at 320 nm and a decrease in the peak at 420 nm 
when comparing the control (without NaBH4 reduction of the Schiff base) and reaction 
(with NaBH4 reduction of the Schiff base).   The LC-MS results from the analysis of the 
full reaction versus the control when monitoring the absorbance at 325 nm showed two 
peaks in the full reaction that were not apparent in the control (see Figure 2-24).  These 
peptides had retention times of 27.1 and 27.8 minutes.  From previous results, these two 
peaks corresponded to the retention times of the expected PLP-peptides from the 
analysis of CysM.  The LC-MS results from the analysis of the full reaction versus the 
flow-through after the addition of the full reaction on the IMAC column showed that the 
two peaks at 27.1 and 27.8 minutes were no longer apparent (see Figure 2-25).  This 
indicated that the PLP-peptides were bound to the Fe-IMAC column.   
All of the column washings were analyzed using the LC-MS, but only one of the 
fractions contained peptides that absorbed at 325 nm.  The final column washing with 
ammonium bicarbonate pH 7.8 contained two peptides that absorbed at 325 nm with 
retention times of 27.1 and 27.8 minutes (see Figure 2-26).  A comparison between the 
initial full reaction sample (before IMAC treatment) and this final ammonium 
bicarbonate washing showed that the retention times were slightly shifted.
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Figure 2-21.  The HPLC results when measuring fluorescence with an excitation wavelength of 290 nm and an emission 
wavelength of 395 nm.  This figure shows the PLP-peptides at about 29.1 and 29.8 minutes as well as many other irrelevant 
peaks.  The full reaction (with NaBH4 reduction of the Schiff base) is shown in the blue trace and the control (without NaBH4 
reduction of the Schiff base) is shown in the red trace. 
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Figure 2-22.  The HPLC results when monitoring the absorbance of 325 nm.  The blue trace is the trypsin control (with only 
trypsin present), the red trace is the control (without NaBH4 reduction of the Schiff base) and the green trace is the full 
reaction (with NaBH4 reduction of the Schiff base).  This figure shows that only the peaks corresponding to the PLP-peptides, 
with 27.1 and 27.8 minutes retention time, were apparent when monitoring the absorbance (325 nm) of the full reaction.  The 
inset shows a zoomed in version with the full reaction (with NaBH4 reduction of the Schiff base) in the blue trace, the control 
(without NaBH4 reduction of the Schiff base) in the red trace and the trypsin control (with only trypsin present) in the green 
trace. 
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However, the peaks in both these samples corresponded to one another (see Figure 2-
27).   The LC-MS results of the CysM full reaction before IMAC treatment versus the 
final column washing with ammonium bicarbonate pH 7.8 when monitoring the mass 
spectrum are shown in Figure 2-28.  These results showed that Fe-IMAC columns 
separated the PLP-peptides from other peptides within the sample. 
The LC-MS results, when monitoring the mass spectrum, from analyzing the 
peptide in the full reaction (with NaBH4 reduction of the Schiff base) with a retention 
time of 27.1 minutes are shown in Figure 2-29.   The results showed that the m/z value 
was 411.2097 with a “z” value of 4.  The resulting M+H was 1641.8154 Da which 
corresponded to the expected PLP-peptide as discussed previously (NPTGSIKDRPAVR 
- 1410.7811 Da; PLP – 231.0297 Da; resulting in a PLP-peptide of 1641.8108 Da).  The 
LC-MS results, when monitoring the mass spectrum, from analyzing the peptide in the 
full reaction (with NaBH4 reduction of the Schiff base) with a retention time of 27.8 
minutes are shown in Figure 2-30.   These results showed that the m/z value was 
431.8200 with a “z” value of 5.  The resulting M+H was 2155.0688 Da which 
corresponded to the expected PLP-peptide as discussed previously 
(LEDRNPTGSIKDRPAVR - 1924.0358 Da; PLP – 231.0297 Da; resulting in a PLP-
peptide with a mass of 2155.0558 Da).  The results showed that the PLP-peptides bound 
to the Fe-IMAC column.  These peptides were eluted when the column was washed with 
25 mM ammonium bicarbonate pH 7.8.  The masses of the peptides with retention times 
of 27.1 and 27.8 minutes were 1641.8154 Da and 2155.0688 Da, respectfully (as 
expected and discussed earlier).   
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Figure 2-23.  The UV-vis spectra results from the reduction of purified CysM for IMAC enrichment.  This figure shows  the 
successful reduction of the PLP-CysM through a decrease in the peak at 420 nm and an increase in the peak at 320 nm. 
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Full Reaction CysM_1-F,4_01_628.d: UV Chromatogram, 325 nm NaBH4 Control_1-F,3_01_627.d: UV Chromatogram, 325 nm  
Figure 2-24. LC-MS results comparing the CysM full reaction and the control before IMAC enrichment.  The result, when 
monitoring the absorbance of both samples at 325 nm, from the full reaction (with NaBH4 reduction of the Schiff base) is 
shown in the pink trace and the control (without NaBH4 reduction of the Schiff base) is shown in the blue trace.   The figure 
shows the successful NaBH4 reduction of the Schiff base as well as the successful trypsin digest.  The PLP-peptides with 
retention times of 27.1 and 27.8 minutes were apparent in the reaction when monitoring at 325 nm, but not in the control. 
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Full Reaction CysM_1-F,4_01_628.d: UV Chromatogram, 325 nm
Sample A - Flow  Through_1-F,5_01_629.d: UV Chromatogram, 325 nm  
Figure 2-25. LC-MS results comparing the CysM full reaction and the flow-through after the IMAC enrichment.  The full 
reaction (with NaBH4 reduction of the Schiff base) is shown in the pink trace and the flow-through after the addition of the 
full reaction on the IMAC column is shown in the blue trace when monitoring the absorbance of both samples at 325 nm.  
This figure shows the PLP-peptides with retention times of 27.1 and 27.8 minutes were apparent in the reaction when 
monitoring at 325 nm.  The flow-through trace shows that the PLP-peptides were no longer in the sample after enrichment 
with the Fe-IMAC column. 
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Sample M - ABC pH 7.8 1_1-E,9_01_640.d: UV Chromatogram, 325 nm  
Figure 2-26. LC-MS results of the final column washing with ammonium bicarbonate pH 7.8 when monitoring the 
absorbance at 325 nm.  The figure shows that the PLP-peptides with retention times of 27.1 and 27.8 minutes were eluted 
when the column was washed with 25 mM ammonium bicarbonate pH 7.8. 
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Full Reaction CysM_1-F,4_01_628.d: UV Chromatogram, 325 nm
Sample M - ABC pH 7.8 1_1-E,9_01_640.d: UV Chromatogram, 325 nm  
Figure 2-27.  LC-MS results when comparing the full reaction and the final column washing after the IMAC enrichment.  The 
results of the full reaction (with NaBH4 reduction of the Schiff base) is shown in the green trace and the final column washing 
with ammonium bicarbonate pH 7.8 is shown in the pink trace, when monitoring the absorbance of both samples at 325 nm.  
The figure shows that the PLP-peptides had approximately the same retention times when comparing the samples before and 
after Fe-IMAC enrichment. 
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Figure 2-28.  LC-MS results of the full reaction and the final column washing with ammonium bicarbonate pH 7.8 when 
monitoring the mass spectrum.  The results of the full reaction (with NaBH4 reduction of the Schiff base) before IMAC 
treatment is shown in the blue trace and the final column washing with ammonium bicarbonate pH 7.8 is shown in the orange 
trace, when monitoring the mass spectrum of both samples.  This figure shows that the PLP-peptides were specifically 
enriched using the Fe-IMAC column. 
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Figure 2-29.  LC-MS results of the final column washing (with ammonium bicarbonate pH 7.8) by analyzing the mass 
spectrum of the peptide with a retention time of 27.1 minutes.  The figure shows that the m/z value, of the peptide with a 
retention time of 27.1 minutes, was 411.2097 with a “z” value of 4.  The resulting M+H was 1641.8154 Da which 
corresponded to the expected PLP-peptide (NPTGSIKDRPAVR - 1410.7811 Da; PLP – 231.0297 Da; resulting in a PLP-
peptide of 1641.8108 Da).   
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Figure 2-30. LC-MS results of the final column washing (with ammonium bicarbonate pH 7.8) by analyzing the mass 
spectrum of the peptide with a retention time of 27.8 minutes.  This figure shows the m/z value, of the peptide with a retention 
time of 27.8 minutes, was 431.8200 with a “z” value of 5.  The resulting M+H was 2155.0688 Da which corresponded to the 
expected PLP-peptide (LEDRNPTGSIKDRPAVR - 1924.0358 Da; PLP – 231.0297 Da; resulting in a PLP-peptide of 
2155.0558 Da).   
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2.3 Discussion 
 The HPLC analysis of the PLP-peptides showed that fluorescence was not a very 
selective method for separating the PLP-peptides from the peptide mixture.  When the 
fluorescence was monitored with an excitation wavelength of 290 nm and an emission 
wavelength of 395 nm, there were many irrelevant peaks present.  These irrelevant peaks 
weren’t apparent when monitoring the absorbance at 325 nm.  As a result, monitoring 
the fluorescence was not as selective as when the absorbance was monitored at 325 nm. 
 The LC-MS analysis of the PLP-peptides from CysM proved to be a successful 
method for determining which peptide peaks corresponded to those bound to PLP.  By 
monitoring at 325 nm, the PLP-peptide(s) were successfully located and analyzed based 
upon their mass spectrum.  The two peaks that were consistently apparent in the reaction 
samples (with NaBH4 reduction of the Schiff base), but not in the control (without 
NaBH4 reduction of the Schiff base) corresponded to the correct M+H values for 
expected PLP-peptides.  The first peptide with a retention time of 27.1 minutes had an 
M+H value of 1641.8154 Da.  Based upon the protein sequence and trypsin digestion, 
the amino acid sequence of this peptide was NPTGSIKDRPAVR with an M+H of 
1410.7811 Da.  As expected, the covalent addition of PLP resulted in an increase of 
231.0297 Da which ultimately resulted in an M+H 1641.8108 Da in the reaction sample.  
The second peptide with a retention time of 27.8 minutes had an M+H value of 
2155.0688 Da.  Based upon the protein sequence and trypsin digestion, the amino acid 
sequence of this peptide was LEDRNPTGSIKDRPAVR with a M+H of 1924.0358 Da.  
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As expected, the covalent addition of PLP resulted in an increase of 231.0297 Da which 
ultimately resulted in an M+H of 2155.0558 Da in the reaction sample.  
 These findings were important because they showed that LC-MS would be useful 
for determining PLP-peptides from complex peptide mixtures.  Although there were 
many other peptide fragments that resulted from the trypsin digestion, monitoring at 325 
nm made it possible to locate the PLP-peptide(s).  Using the mass spectrum of the 
sample, it was possible to determine the mass of the resulting PLP-peptide fragment was 
determined.  This study was relevant because it provided proof of concept that it would 
be possible to analyze cell lysate proteomes for PLP-peptides. Even though monitoring 
the absorbance at 325 nm made it possible to locate the PLP-peptides, the peptide 
mixture was still very complex for each sample.  The mass spectrum was complex with 
many peptide peaks.  Although the mass spectrum peak that corresponded to the 
absorbance peak, when monitoring the absorbance at 325 nm, could be determined from 
the digestion of a pure PLP-enzyme, it may be difficult to determine the mass of a PLP-
peptide from a cell lysate.  Therefore, it may be necessary to enrich the samples for PLP-
peptides prior to analysis with LC-MS in order to decrease the number of irrelevant 
peptides in the sample. 
 Fe-IMAC was a successful method for specifically enriching the PLP-peptides.   
The mass spectrum of the entire CysM lysate was very complex with many peaks 
corresponding to various peptides.  After enrichment using the Fe-IMAC column, the 
mass spectrum was simplified to mainly contain the PLP-peptide peaks, which had 
retention times of 27.1 and 27.8 minutes.  Overall, the results showed that the PLP-
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peptides specifically bound to the Fe-IMAC column and were eluted when the column 
was washed with 25 mM ammonium bicarbonate pH 7.8.  Overall, the IMAC column 
was successful at specifically enriching PLP-peptides and may be a useful method for 
studying the proteomics of PLP-dependent enzymes or the “PLP-ome.” 
 Future research should include attempting to analyze the proteome of cell lysates 
from various organisms.  When applying this methodology to a cell lysate it may be 
necessary to make slight variations.  For example, it may be necessary to complete the 
NaBH4 reduction under denaturing conditions.  It may also be necessary to add the cell 
lysate to the Fe-IMAC column multiple times in order to allow the PLP-peptides to be 
enriched before analysis on the LC-MS.  It may also be possible to mix the cell lysate 
with the Fe-NTA resin in a batch reaction rather than using a column.  This would allow 
constant mixing between the PLP-peptides and the resin and may enhance the 
enrichment of the PLP-peptides.   
 
2.4 Experimental 
2.4.1 CysM Expression and Purification.  The gene source of CysM was 
Mycobacterium tuberculosis, the plasmid was pET16b (Ampicillin resistant) and the 
storage strain was DH5alpha.  The storage strain was grown on an Amp-LB plate 
overnight for 14 hours.  A single colony from this plate was used to inoculate a 15 mL 
starter culture consisting of ampicillin (Amp) and LB (15 µL of 100 mg/ml ampicillin).  
This culture was then incubated in the small shaker at 37°C for approximately 15 hours.  
The culture was then centrifuged for 10 minutes at 5000 RPM.  The supernatant was 
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then discarded and the pellets were resuspended in 250 μL Buffer P1 according to the 
QIAprep Spin MiniPrep kit for plasmid DNA purification.  The second step of the 
MiniPrep kit called for the addition of 250 μL of Buffer P2 and inversion of the 
eppendorf tube.  Next, 350 μL of Buffer N3 was added and mixed immediately.  The 
eppendorf tubes were then centrifuged for 10 minutes at 13,000 RPM.  The supernatants 
were applied to the QIAprep spin columns by pipetting.  The spin columns were 
centrifuged for 60 seconds and the flow-through was discarded.  The QIAprep columns 
were washed by adding 500 μL of Buffer PB and centrifuged for 60 seconds.  The 
columns were washed two more times with 750 μL of Buffer PE and centrifuged for an 
additional 60 seconds.  The flow-through was discarded and centrifuged for an 
additional minute to remove residual wash buffer.  The columns were then placed in 
clean 1.5 mL eppendorf tubes.  The DNA was eluted by adding 50 μL of Buffer EB to 
the center of each spin column then they were left standing for one minute and then 
centrifuged for one minute.  Before beginning the transformation, two electrocuvettes 
were placed on ice and two Amp-LB plates were placed in the 37°C incubator.   
The electroporation process required the dilution of the MiniPrep product using 1 
µL of MiniPrep solution and 19 µL of sterile H2O.  One µL of the above diluted 
MiniPrep product was added to approximately 40 µL of electrocompetent E. Coli BL21 
(DE3) cells and then transferred to the sterile electrocuvettes that were placed on ice at 
the beginning of this process.  All air bubbles were removed from the cuvette before 
being placed in the electroporator.  A pulse of 2.5 kV was used to increase the 
permeability of the plasma membrane to allow the transformation of the cells.  The cells 
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were then “rescued” from the cuvette by adding 1 mL of LB and transferring to sterile 
eppendorf tubes.  These tubes were then incubated in the shaker for 45 minutes at 37°C.  
About 100 µL of the incubated cells were then plated on a warmed  
Amp-LB plate and incubated overnight at 37°C.  A single colony was used to inoculate a 
15 ml LB culture with 15 µL 100 mg/mL Amp.  This culture was then incubated 
overnight for 12-15 hours at 37°C 200 RPM.  This single colony culture was then used 
to inoculate a large 1 L AMP-LB culture and grown up to an OD600 of 0.6 at 37°C, 200 
RPM.  This culture was then placed in the cold room for approximately 20 minutes and 
the shaker was decreased to 15°C and 180 RPM.  Protein production was induced using 
isopropyl β-D-1-thiogalactopyranoside (IPTG) (CF 1 mM) and the culture was placed in 
the shaker.  After 0 hrs, 3 hrs, 6 hrs and 20 hrs, aliquots were taken to run on a SDS-
PAGE gel to monitor the expression of CysM. 
 A 12% SDS-PAGE gel was made and used to check the protein production after 
inducing with IPTG.  Each aliquot of cells was mixed with 10 µL of loading dye with 
DTT.  These samples were then incubated for 10 minutes at 100°C using the PCR 
machine.  The samples were then centrifuged 2-3 minutes at 14,000 RPM.  The samples 
were loaded into a 12% SDS-PAGE gel and run at 120 V for about 1.5 hours.  
The following buffers were made: Start/Lysis Buffer – 50 mM KH2PO4, 150 mM 
NaCl, pH 7.8; Elution Buffer – 50 mM KH2PO4, 150 mM NaCl, 500 mM Imidazole, pH 
7.8; 2x Final Buffer – 100 mM KH2PO4, 300 mM KCl, 30% glycerol, pH 7.5; IMAC 
Strip Buffer – 20 mM NaH2PO4, 500 mM NaCl, 50 mM EDTA, pH 7.4.  The Elution 
and Start Buffers were combined to form buffers with the following concentrations of 
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imidazole: 10 mM, 50 mM, 100 mM, 200 mM (all buffers also contained 50 mM 
KH2PO4, 150 mM NaCl, pH 7.8). 
The purification procedure required the cell pellet to be thawed and resuspended 
in 10 mL of 10 mM Imidazole, 50 mM KH2PO4, 150 mM NaCl, pH 7.8 buffer.  The 
cells were then sonicated six times with a process time of 20 seconds, 1.5 seconds on 
and 1.5 seconds off at a 5.0 output.  A 100 µL aliquot was then removed prior to 
spinning down the sonicated cells at 15,000 RPM for 35 minutes.  The 100 µL aliquot 
was also spun down at 14,000 RPM for 5 minutes.  The cell pellet and supernatants were 
separated for both the large sample as well as the small 100 µL sample.  TCEP was then 
added to 5 mL aliquots of each buffer for purification containing varying concentrations 
of imidazole (CF 1 mM).  A Ni-IMAC column (1 mL) was prepared by running 5 cv 
water, 5 cv strip buffer, 5 cv water, 5 cv 0.1M NiSO4, 5 cv water, and 5 cv of the 10 mM 
imidazole buffer (50 mM KH2PO4, 150 mM NaCl, pH 7.8).  The cell lysate was filtered 
through a syringe filter and then loaded onto the column.  An imidazole gradient was 
then applied by adding 5 cv 10 mM imidazole, 5 cv 50 mM imidazole, 5 cv 100 mM 
imidazole, 5 cv 200 mM imidazole, and 5 cv 500 mM imidazole (all imidazole buffers 
also included 50 mM KH2PO4 and 150 mM NaCl pH 7.8).  The column was then 
washed with 5-10 cv water, 5 cv strip buffer, 5 cv water and 5 cv 10% ethanol.   
A 12% SDS-PAGE gel was then prepared and the gel samples were prepared as 
follows: Expression samples - 0 hr and 20 hrs from previous gel; Supernatant/Pellet - 5 
µL of the supernatant/pellet sample + 15 µL of the 10 mM imidazole + 10 µL loading 
dye; IMAC fractions – 20 µL sample + 10 µL dye.  The samples were then boiled in the 
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PCR thermal cycler at 100°C for 10 minutes except for the pellet sample which was 
boiled for 20 minutes.  The samples were then spun about 2 minutes at 14,000 RPM.  
The gel was loaded with 8 µL of the marker and 10 µL of each sample (resulting in 10 
samples in total).  The samples containing the CysM protein were then desalted and 
buffer exchanged into 1x final buffer consisting of 50 mM KH2PO4, 150 mM KCl, 15% 
glycerol, pH 7.5 before being concentrated to a final concentration of 130 µM.   
2.4.2 CysM Reduction Under Basic Conditions.  A solution of 0.24% (w/v) 
NaOH was made fresh before the hydrogenation reaction.  Two separate assays were set 
up as follows: 1) 50 µL of 50 mM CysM (in 1x final buffer consisting of 50 mM 
KH2PO4, 150 mM KCl, 15% glycerol, pH 7.5) + 15 µL 10 mM NaBH4 in 0.24% NaOH; 
2) 50 µL of 50 mM CysM (in 1x final buffer consisting of 50 mM KH2PO4, 150 mM 
KCl, 15% glycerol, pH 7.5) + 15 µL 0.24% NaOH.  The UV-vis spectrum was obtained 
after various reaction times.  The samples that were reacted with NaBH4 for 5 minutes 
were buffer exchanged into 20 mM ammonium acetate using the Biospin Buffer 
exchange columns and were then concentrated down in order to analyze the samples via 
mass spectroscopy.  The final concentration of the reaction was 40 µM at 50 µL and the 
final concentration of the control (without NaBH4 reduction of the Schiff base) was 50 
µM at 50 µL.   
2.4.3 CysM Reduction Under Neutral Conditions.  Two separate assays were set 
up as follows: 1) 50 µL of 50 mM OAHS (in 1x final buffer consisting of 50 mM 
KH2PO4, 150 mM KCl, 15% glycerol, pH 7.5) + 15 µL 10 mM NaBH4 in dH2O; 2) 50 
µL of 50 mM OAHS (in 1x final buffer consisting of 50 mM KH2PO4, 150 mM KCl, 
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15% glycerol, pH 7.5) + 15 µL in dH2O.  The UV-vis spectrum was obtained after a one 
hour reaction time.  The samples were buffer exchanged into 20 mM ammonium acetate 
using the Biospin Buffer exchange columns and were then concentrated down in order to 
analyze the samples via mass spectroscopy.  The final concentration of the reaction was 
40 µM at 50 µL and the final concentration of the control (without NaBH4 reduction of 
the Schiff base) was 50 µM at 50 µL.  
2.4.4 Immobilized Ion Metal Affinity Chromatography Enrichment.  Two 50 µL 
samples of 100 µM CysM were thawed and buffer exchanged into 100 mM HEPES pH 
7.8.  A 1 M NaBH4 solution (in 0.24% NaOH) was made and 10 µL were added to the 
reaction samples while 10 µL of 0.24% NaOH were added to the control solution 
(without NaBH4 reduction of the Schiff base).  The reaction proceeded undisturbed, in 
the dark, for 5 minutes.  The samples were then buffer exchanged into 50 mM 
ammonium bicarbonate (ABC) pH 7.8.  The resulting concentrations of the control 
(without NaBH4 reduction of the Schiff base) and reaction (with NaBH4 reduction of the 
Schiff base)were 4 µM with volumes of 60 µL.  The samples were thermally denatured 
by incubating at 90°C for 20 minutes before being quenched with ice water for 5 
minutes.  The thermally denatured protein was then enzymatically digested with 
sequencing grade trypsin for 5 hours at 37°C.  The concentration of trypsin was 
maintained at 40:1 (weight of substrate: weight of trypsin).  The trypsin digested 
proteins were then stored in the freezer until being enriched with Fe-IMAC. 
The procedure for making the Fe-IMAC column was obtained from Phillip Lang 
(Dr. Russel’s research group).  A 200 μL pipette tip was obtained and glass wool was 
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placed at the bottom for packing.  Then, 50 μL of NTA-agarose resin was added and a 
pipette was used to push through the solution and pack the beads.  Next, the beads were 
washed by adding 50 μL of 0.1 M acetic acid three times and then a pipette was used to 
push through the solution after letting it flow through the column by gravity about 1 
hour.  The beads were then charged with FeCl3 (60 mM) in 0.1 M acetic acid by adding 
50 μL of 60 mM FeCl3 followed by another 50 μL of 60 mM FeCl3 in 0.1 M acetic acid.  
The column was kept at room temperature for 30 minutes.  A pipette was used to push 
through the FeCl3 eluent before a third aliquot of 50 μL FeCl3 was added to the column 
and a pipette was used to push through the solution.  Next, the column was washed with 
50 μL dH2O three times and then the column was washed with 0.1 M acetic acid an 
additional three times. 
The peptides were added to the column through the following procedure.  
Approximately 10 μL of peptides were mixed with 50 μL of 0.1 M acetic acid before the 
entire 60 µL solution was added to the column.  A pipette was used to push the solution 
through slightly before the tip was capped and incubated at 37˚C for 30 minutes.  The 
following procedure was then used to collect the peptides from the column.  First, the 
column was washed with 50 μL of dH2O three times while the flow-through was 
collected.  Then 50 μL of acetic acid (0.1 M) was used to wash the column three times 
while the flow-through was collected.  The column was then washed with 50 µL of 
dH2O while the flow-through was collected.  Next, the peptides were eluted with 50 μL 
0.1 M Ammonium bicarbonate, 20% Acetonitrile pH = 9 three times while collecting the 
flow-through.  The peptides were then placed in the freezer for storage and the column 
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was covered with parafilm for storage.  The resulting peptide mixtures were analyzed 
using MALDI with the help of Phillip Lang from Dr. Russell’s lab.  
 2.4.5 Trypsin Digest of CysM and Analysis.  Two 50 µL samples of 100 µM 
CysM were thawed and buffer exchanged into 100 mM HEPES pH 7.8.  The resulting 
concentrations of the control (without NaBH4 reduction of the Schiff base) and reaction 
(with NaBH4 reduction of the Schiff base) were and 3.1 mg/ml  (91 µM) and 2.9 mg/ml 
(83 µM) respectfully.  A 1 M NaBH4 solution (in 100 mM HEPES pH 7.8) was made 
and 10 µL were added to the reaction sample while 10 µL of 100 mM HEPES pH 7.8 
were added to the control solution (without NaBH4 reduction of the Schiff base).  The 
reaction proceeded undisturbed, in the dark, for 1 hour.  The samples were then buffer 
exchanged into 25 mM ammonium bicarbonate (ABC) with the following 
concentrations: control – 1.8 mg/ml (53 µM); reaction – 1.8 mg/ml (53 µM).  Finally, 
the samples were enzymatically digested with trypsin in a 40:1 (wt of substrate: wt of 
trypsin) ratio overnight (about 16 hours) at 37°C.   
 HPLC was then used to analyze the trypsin digested samples.  The method 
consisted of a gradient from 100% dH2O + 0.1% formic acid to 100% acetonitrile + 
0.1% formic acid.  The entire method can be seen in Table 2-1.  The total stop-time was 
65 minutes and the total post-time was 7 minutes resulting in a 72 minute run.  A total of 
four samples (35 µL each) were run including the 25 mM ammonium bicarbonate 
control (with only ammonium bicarbonate), the trypsin control (with only trypsin), the 
control (without NaBH4 reduction of the Schiff base) and the full reaction (with NaBH4 
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reduction of the Schiff base).  The wavelengths being monitored were 210 nm, 214 nm, 
254 nm, 280 nm, and 325 nm. 
2.4.6 LC-MS Analysis of the Trypsin Digest of CysM.  The samples resulting 
from the previous trypsin digest without were analyzed with the LC-MS.  The modified 
method is shown in Table 2-2. The post-time was 47 minutes and the total runtime was 
54 minutes.  The following samples were analyzed: buffer control (with only ammonium 
bicarbonate buffer), trypsin control (with only trypsin), CysM control (without NaBH4 
reduction of the Schiff base) and full reaction (with NaBH4 reduction of the Schiff base). 
2.4.7 Purified CysM – Fluorescence Tests.  A 100 µL aliquot of CysM was 
thawed and buffer exchanged into 100 mM HEPES pH 7.8.  The resulting concentration 
was 2.9 mg/ml (85 µM).  This aliquot was split into two CysM aliquots (50 µL each).  A 
1 M NaBH4 solution (in 100 mM HEPES pH 7.8) was made and 10 µL were added to 
the reaction samples while 10 µL of 100 mM HEPES pH 7.8 were added to the control 
samples (without NaBH4 reduction of the Schiff base).   The reaction proceeded 
undisturbed, in the dark, for 1 hour.  The samples were then buffer exchanged into 25 
mM ammonium bicarbonate (ABC) with the following concentrations: control – 1.7 
mg/ml (50 µM), reaction – 1.5 mg/ml (44 µM).   
 The samples were then denatured by adding 10 µL of 40 mM DTT in 100 mM 
ABC.  The samples were reacted for 45 minutes at 50°C before being cooled to room 
temperature.  To acetylate, 10 µL of 220 mM iodoacetamide (made fresh while cooling 
in the previous step) were added to each sample.  The samples were reacted for 30 
minutes at room temperature.  To quench, 50 µL of 40 mM DTT were added to each 
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Table 2-1.  The HPLC method used for the trypsin digest sample analysis.  This table shows the gradient used from 100% 
0.1% formic acid in water up to 100% 0.1% formic acid in acetontrile that was used during HPLC analysis. 
Time (minutes) %B (0.1% Formic Acid/Water) %D (0.1% Formic Acid/ACN) 
0 100 0 
10 98 2 
20 95 5 
60 0 100 
62 0 100 
63 100 0 
65 100 0 
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Table 2-2.  The LC-MS method used for the trypsin digest samples.  This table shows the gradient used from 100% 0.1% 
formic acid in water up to 100% 0.1% formic acid in acetontrile that was used during LC-MS analysis. 
 
Time (minutes) %B (0.1% Formic Acid/Water) %D (0.1% Formic Acid/ACN) 
0 100 0 
10 98 2 
20 95 5 
40 47.5 52.5 
42 0 100 
47 0 100 
49 100 0 
54 100 0 
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sample. Finally, the samples were enzymatically digested by adding trypsin in a 40:1 (wt 
of substrate: wt of trypsin) ratio.  The samples were then reacted overnight (about 16 
hours) at 37°C.  The samples were then quenched with 10 µL of 1% formic acid.  These 
samples were then analyzed using the HPLC with the same method as shown in Table  
2-2.  The specific wavelengths analyzed included 214 nm, 254 nm, 325 nm as well as 
fluorescence. 
2.4.8 Modified IMAC Enrichment.   A 100 µL sample of 100 µM CysM was 
thawed and buffer exchanged into 100 mM HEPES pH 7.8.  The resulting concentration 
was 3.5 mg/ml (100 µM).  This sample was then split into two even aliquots (35 µL 
each).  A 1 M NaBH4 solution (in 100 mM HEPES pH 7.8) was made and 10 µL were 
added to the reaction sample while 10 µL of 100 mM HEPES pH 7.8 were added to the 
control sample (without NaBH4 reduction of the Schiff base).  The reaction proceeded 
undisturbed, in the dark, for 1 hour.  The samples were then buffer exchanged into  
25 mM ammonium bicarbonate (ABC) with the following concentrations: control – 1.7 
mg/ml (50 µM); reaction – 1.5 mg/ml (50 µM).  Finally, the samples were enzymatically 
digested by adding trypsin in a 40:1 (wt of substrate: wt of trypsin) ratio.  The samples 
were then reacted overnight (about 16 hours) at 37°C.    
Three IMAC columns were prepared using three 200 µL pipette tips with glass 
wool placed at the tip for packing.  Next, 50 µL of NTA-agarose resin was added to each 
tip.  A pipette was used to push through the solution and pack the beads.  The beads 
were then washed by adding 50 µL of 0.1 M Acetic acid five times, using a pipette to 
push through each aliquot after letting flow by gravity for 15 minutes each.  The beads 
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were then charged with FeCl3 (60 mM) in 0.1 M acetic acid by the addition of 50 µL of 
60 mM FeCl3.  Another 50 µL of 60 mM FeCl3 in 0.1 M acetic acid was added and 
reacted at room temperature for 30 minutes.  A pipette was used to push through the 
FeCl3 eluent.  A third aliquot of 50 µL FeCl3 was added to column and pushed through 
with a pipette.  The column was then washed with 50 µL dH2O three times.  Finally, the 
column was washed three times with 50 µL of 0.1 M acetic acid. 
 To quench the trypsin, 10 µL of 1% formic acid was added to each sample.  To 
prepare the peptide solution, an additional 10 µL of 1% formic acid was added to each 
sample which decreased the pH to 3-4.  The peptides were then added to the column in 
50 µL increments.  For each increment, a pipette was used to slightly push the solution 
through the column before the column was capped and incubated at 37°C for 30 minutes.  
The peptides were added in this manner (in 50 µL increments) until all the peptide 
solution has been passed over the column.  The resulting flow-through was then added to 
the column one more time before the column was capped and incubated at 37°C for 30 
minutes. 
To collect the peptides, the column was first washed with 50 µL of dH2O three 
times while the flow-through was collected.  The column was then washed with 50 µL of 
acetic acid (0.1 M) three times while the flow-through was collected.  The column was 
then washed one more time with 50 µL of dH2O while the flow-through was collected.  
The column was then washed with 50 µL 0.1 M ammonium bicarbonate, 20% 
acetonitrile pH = 9 three times to potentially elute the PLP-peptides while the flow-
through was collected.  The column was then washed twice with 0.1 M phosphoric acid 
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while the flow-through was collected.  Finally, the column was washed once with 25 
mM Ammonium bicarbonate pH 7.8 while the flow-through was collected.  The 
fractions were then analyzed using the LC-MS with the same RP C18 column and 
method as used previously (Table 2-2). 
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3. SUMMARY AND CONCLUSIONS 
3.1  Summary 
 CysM was a suitable model for PLP-peptide proteomics and method 
development.  The CysM was successfully purified from E. coli BL21 DE3 using nickel 
affinity chromatography.  The reduction of the Schiff base with NaBH4 was 
characterized using both UV-visible spectroscopy as well as mass spectrometry.  When 
analyzing with UV-visible spectroscopy, a new peak formed as a “shoulder” at 
approximately 320 nm and the absorbance at 420 nm decreased when the Schiff base 
was reduced.  When analyzing with mass spectrometry an increase of 231.0297 Da was 
expected, and seen, due to the covalent bond formed after the reduction.   
 For the enrichment of PLP-proteins, an initial attempt at immobilized ion metal 
affinity chromatography did not result in any peptides within the ammonium bicarbonate 
washings, where any bound phosphoproteins were expected to elute.   Based upon the 
fragmentation from trypsin digestion, the following peptides were expected: 1) 
LEDRNPTGSIK – 1229.6484 Da; w/ PLP bound – 1460.6781 Da; 2)  NPTGSIK – 
716.3937 Da; w/ PLP bound – 947.4234 Da; 3)  NPTGSIKDRPAVR – 1410.7811 Da; 
w/ PLP bound – 1641.8108 Da.  These results indicated that either the Fe-IMAC 
procedure would need to be modified for PLP-peptides or another enrichment method 
would need to be used to enrich and/or visualize the PLP-peptides. 
 CysM was then analyzed using LC-MS after trypsin digestion.  The method 
consisted of a gradient from 100% dH2O + 0.1% formic acid to 100% acetonitrile + 
0.1% formic acid.  The wavelengths monitored included 214 nm, 254 nm, 280 nm and 
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325 nm.  At least one peak, corresponding to a PLP-peptide, was expected when 
monitoring the full reaction at 325 nm.  This particular peak was not expected to be 
apparent in the control (without NaBH4 reduction).  It was expected and found that 
monitoring at 325 nm would select specifically for the PLP-peptide(s).  The results 
showed that there were two peaks in the full reaction that were not apparent in the 
control (without NaBH4 reduction of the Schiff base) with retention times of 
approximately 27.1 and 27.8 minutes.  Analyzing the mass spectrum at these retention 
times resulted in M+H values of 1641.8108 Da and 2159.1015 Da.  These two M+H 
values corresponded to the following expected peptides with PLP-bound to the active 
site lysine (Lys51): 1) NPTGSIKDRPAVR; 2) LEDRNPTGSIKDRPAVR.   
 The enzymatically digested CysM was also analyzed by monitoring the 
fluorescence of the PLP-peptide.  The best fluorescence wavelengths to monitor 
included an excitation of 290 nm and an emission of 395 nm.  Although peaks 
corresponding to the PLP-peptides were apparent, this method for monitoring PLP-
peptides was not as sensitive as monitoring by absorbance at 325 nm.  There were many 
other peaks that were apparent at various retention times.   
 Due to the complexity of a cell lysate, the enrichment method Fe-IMAC was 
attempted once again with a modified procedure.  The LC-MS results from the analysis 
of the full reaction versus the control (without NaBH4 reduction of the Schiff base) 
showed two peaks, eluting at 27.1 and 27.8 minutes, in the full reaction that are not 
apparent in the control.  The LC-MS results from the analysis of the full reaction versus 
the flow-through, after the addition of the full reaction on the IMAC column, showed 
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that the two peaks at 27.1 and 27.8 minutes were no longer apparent.  This indicated that 
the PLP-peptides were bound to the Fe-IMAC column.  The final column washing with 
ammonium bicarbonate pH 7.8 contained two peptides that absorbed at 325 nm with 
retention times of 27.1 and 27.8 minutes.  The LC-MS results of the CysM full reaction 
before IMAC treatment versus the final column washing with ammonium bicarbonate 
pH 7.8, when monitoring the mass spectrum, showed that the treatment using the IMAC 
column separated the PLP-peptides from all other peptides within the sample.  Overall, 
the Fe-IMAC column specifically enriched the PLP-peptides and may be a useful 
method for studying the proteomics of PLP-dependent enzymes. 
 
3.2 Conclusions 
 In conclusion, a method was developed to analyze and identify PLP-peptides 
when using CysM as a model system.  The Schiff base was reduced with NaBH4 which 
was monitored by either UV-vis spectroscopy, through an increase at 320 nm and a 
decrease in absorbance at 420 nm or mass spectrometry, through the increase in mass of 
231.0297 Da.  Trypsin was used to enzymatically digest the reduced CysM before being 
it was analyzed using LC-MS.  The PLP-peptide(s) was located in the peptide mixture 
by monitoring the absorbance at 325 nm.  The mass spectrum was then be used to 
confirm the PLP-peptide(s).  The PLP-peptides were also specifically enriched by using 
Fe-IMAC columns and eluted with an ammonium bicarbonate buffer pH 7.8.  This 
enrichment method may provide an opportunity to identify and analyze PLP-peptides in 
complex peptide mixtures. 
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Following this method development, PLP-dependent enzymes in a cell lysate 
could be analyzed in a fairly quick and efficient manner.  The combination of genomic 
and biochemical information gained from this type of study could be used to address 
detailed questions about PLP-dependent enzymes.  For example, which PLP-dependent 
enzymes are minimally required for an organism to survive in a strained or favorable 
environment?  How do these enzymes differ in quantity and function between a basic 
prokaryote versus a more complex higher eukaryote?  Can novel, unclassified, PLP-
dependent enzymes be uncovered through the use of this genomic and biochemical 
approach?  Answering these questions could lead to substantial biochemical 
advancements which may further our understanding of complex biological processes. 
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